A meta-analysis of the relative risk of mortality for type 1 diabetes patients compared to the general population: exploring temporal changes in relative mortality. by Tom W C Lung, Alison J Hayes, William H Herman, Lei Si, Andrew J Palmer, Philip M Clarke

Get full text

Predicting Changes in Cardiovascular Risk Factors in Type 2 Diabetes in the Post-UKPDS Era: Longitudinal Analysis of the Swedish National Diabetes Register by Aliasghar Ahmad Kiadaliri, Philip M. Clarke, Ulf-G. Gerdtham, Peter Nilsson, Björn Eliasson, Soffia Gudbjörnsdottir, Katarina Steen Carlsson

Get full text

Reducing inequalities through greater diversity in clinical trials – As important for medical devices as for drugs and therapeutics by Laurence S.J. Roope, Jessica Walsh, Maddie Welland, Gabrielle Samuel, Heidi Johansen-Berg, Anna C. Nobre, Stuart Clare, Helen Higham, Jon Campbell, Tim Denison, Karla L. Miller, Seena Fazel, Matthew L. Costa, Andrew Farmer, Marian Knight, Rachel Taylor, Lorna R. Henderson, Angeli Vaid, John Geddes, Vasiliki Kiparoglou, Helen McShane, Philip M. Clarke

Get full text

Six months of hybrid closed-loop therapy improves diabetes-specific positive well-being, and reduces diabetes distress and fear of hypoglycemia: secondary analysis of a randomized... by Anthony C Keech, Vijaya Sundararajan, Bruce R King, Sara Vogrin, Richard J MacIsaac, Leon A Bach, Jane Speight, Alicia J Jenkins, Christel Hendrieckx, David O’Neal, Sybil A McAuley, Geoff R Ambler, Fergus J Cameron, Jan M Fairchild, Elizabeth A Davis, Timothy W Jones, Morton G Burt, Philip M Clarke, Neale D Cohen, Peter G Colman, Joey Kaye, Kavita Kumareswaran, Melissa H Lee, Roland W Mccallum, Barbora Paldus, Stephen N Stranks, Steven Trawley, Glenn M Ward, David N O’Neal, Sienna Russell-Green, Deborah Jane Holmes-Walker, Benjamin Lam, Jennifer A Halliday, Glenn Ward, Catriona M Sims, D Jane Holmes-Walker, Andrzej Januszewski, Hanafi Mohammed Husin, Martin I de Bock, Mary B Abraham

Get full text